Incubate CoalitionJun 14, 2021What M&A Critics Don’t Understand About Drug InnovationWe want brilliant minds at thousands of small, unheard-of biotechs chasing tomorrow’s cures. But they can only do so if larger...
Incubate CoalitionJun 11, 2021The Pathway To Drug Development Driven By Private CapitalVideo narrated by Sara Nayeem, Avoro Ventures
Incubate CoalitionFeb 25, 2021FINAL NIST Oral Testimony – John Stanford, IncubateWe're here today to lend our strong support to the proposed clarification of the appropriate use of "march-in" authority under Bayh Dole....
Incubate CoalitionFeb 18, 2021Mergers And Acquisitions: A Key Driver Of VC Investment In HealthcareThe drug pricing debate is a worthy one. We have to have open discussions about maximizing innovation and access. But half-written...
Incubate CoalitionJan 26, 2021Most Favored Nation (MFN) Model Interim Final Rule With Comment PeriodIncubate writes to share our strong concerns with the interim final rule (IFR) implementing the Most Favored Nation (MFN) Model. We...